GlassScriptPhysician profile
Jonathan B Lupton
NPI 1013903541
$3,902.30
in general payments reported to CMS, 2019-2025
44 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $339 · 2021: $498 · 2022: $874 · 2023: $730 · 2024: $507 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $631.06 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $419.26 | 2021-2025 | |
| Hologic Sales and Service, LLC | $331.50 | 2019-2024 | Coolseal Generator, Acessa Provu System, Omni Hysteroscope |
| Coopersurgical, INC. | $224.60 | 2019-2025 | Paragard T 380a, Endosee |
| Bayer Healthcare Pharmaceuticals INC. | $214.38 | 2019-2025 | |
| Pfizer INC. | $194.19 | 2019-2024 | |
| Astellas Pharma US INC | $191.01 | 2019-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $179.03 | 2020-2025 | Slynd |
| Therapeuticsmd, INC. | $156.68 | 2019-2022 | |
| Aspira Women'S Health INC | $128.17 | 2022 | |
| Myovant Sciences INC. | $106.36 | 2021-2022 | |
| Biogen, INC. | $73.50 | 2025 | Zurzuvae |
| Millicent US INC | $70.65 | 2024-2025 | Femlyv, Intrarosa |
| Minerva Surgical, INC | $69.37 | 2019-2023 | |
| Medtronic, INC. | $63.66 | 2022-2023 | Interstim |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $57.57 | 2024 | Saxenda, Wegovy |
| Coloplast Corp | $51.02 | 2022-2023 | Saffron, Altis |
| Meditrina | $48.71 | 2022 | |
| Agile Therapeutics, INC. | $48.00 | 2022 | |
| Shield Therapeutics INC | $46.45 | 2022-2023 | Accrufer |
| Covidien LP | $45.24 | 2019 | |
| Organon LLC | $44.75 | 2021-2025 | Nexplanon |
| Avion Pharmaceuticals | $36.70 | 2019-2022 | |
| Medicem INC. | $35.61 | 2021-2023 | |
| Boston Scientific Corporation | $35.04 | 2019 | |
| Daiichi Sankyo INC. | $32.25 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $32.04 | 2024 | |
| Scynexis, INC. | $29.19 | 2022 | |
| 180 Medical, INC. | $29.11 | 2024 | |
| Exact Sciences Corporation | $28.66 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $27.72 | 2019 | |
| Lupin INC. | $25.48 | 2019 | |
| Duchesnay USA Incorporated | $24.68 | 2019 | |
| Mylan Pharmaceuticals INC. | $23.27 | 2022 | |
| Sumitomo Pharma America, INC. | $18.92 | 2023 | Myfembree |
| Axonics, INC. | $18.54 | 2023 | Bulkamid, Axonics |
| Hologic INC | $17.26 | 2019 | |
| Ethicon US, LLC | $15.34 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $15.06 | 2019 | |
| Sanara Medtech INC. | $13.81 | 2021 | |
| Dysis Medical, INC. | $13.72 | 2020 | |
| Asensus Surgical, INC. | $12.21 | 2019 | |
| Merck Sharp & Dohme LLC | $11.30 | 2020 | |
| Evofem Biosciences, INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lupton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.